Eikon Therapeutics Inc. – Filings and Transcripts

NASDAQ: EIKN
Share price (6/2/26): $9.60
Market cap (6/2/26): $520 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement with pricing info

Addition of securities to prior initial registration

Registration of securities on exchange

Initial registration of new securities – amended

Ownership Filter

Innovation Endeavors III LP

Perlmutter Roger M

BlackRock Portfolio Management LLC

Klobuchar Michael A

News Filter

Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

Reports First Quarter 2026 Financial Results and Provides Clinical Updates

Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Proxies

No filings in this category.

Other Filter

Notice of effectiveness